Related Experiment Video

Updated: Jun 17, 2026

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach
11:11

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach

Published on: February 21, 2019

Identification of four novel phosphorylation sites in estrogen receptor alpha: impact on receptor-dependent gene

Christopher C Williams1, Aninda Basu, Abeer El-Gharbawy

  • 11Division of Basic Pharmaceutical Sciences, College of Pharmacy, Xavier University of Louisiana, New Orleans, LA, USA. cwillia0@tulane.edu

BMC Biochemistry
|January 2, 2010
PubMed
Abstract

Insights

Researchers identified novel phosphorylation sites on estrogen receptor alpha (ERalpha), revealing new ways to control its activity. These findings are crucial for understanding breast cancer and developing targeted endocrine therapies.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Endocrinology

Background:

  • Estrogen receptor alpha (ERalpha) phosphorylation influences gene transcription, receptor activation, and breast cancer endocrine therapy response.
  • Existing knowledge of ERalpha phosphorylation sites is insufficient to explain its full range of functions.
  • Further investigation is needed to identify additional ERalpha phosphorylation sites.

Purpose of the Study:

  • To identify previously uncharacterized phosphorylation sites on human ERalpha.
  • To investigate the functional consequences of these novel phosphorylation sites on ERalpha activity.
  • To identify kinases responsible for ERalpha phosphorylation at specific sites.

Main Methods:

  • Labeling of COS-1 cells expressing ERalpha with [32P]H3PO4 in vivo.
  • Isolation and analysis of ERalpha tryptic phosphopeptides using Edman degradation and phosphoamino acid analysis.
  • Site-directed mutagenesis, phospho-specific antibody validation, reporter gene assays, and kinase assays.

Main Results:

  • Four novel ERalpha phosphorylation sites were identified: Serines 46/47, 282, 294, and 559.
  • Mutations at Ser-282 and Ser-559 led to ligand-independent ERalpha activation.
  • Mutations at Ser-46/47 and Ser-294 reduced estradiol-dependent reporter activation.
  • Protein kinase CK2 was identified as a kinase phosphorylating ERalpha at Ser-282 and Ser-559.

Conclusions:

  • The newly identified ERalpha phosphorylation sites offer novel mechanisms for modulating ERalpha activity.
  • Serine 559 is the first identified phosphorylation site in the C-terminal F domain of any steroid receptor.
  • These findings provide new targets for understanding and treating ER-dependent conditions, including breast cancer.

More Related Videos

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay09:07

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay

Published on: December 19, 2018

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...